JP2024000504A - Ｈｍｇｂ１の発現制御剤；急性肺損傷、急性呼吸窮迫症候群または敗血症の予防薬または治療薬、あるいはそれらの改善方法 - Google Patents
Ｈｍｇｂ１の発現制御剤；急性肺損傷、急性呼吸窮迫症候群または敗血症の予防薬または治療薬、あるいはそれらの改善方法 Download PDFInfo
- Publication number
- JP2024000504A JP2024000504A JP2023083544A JP2023083544A JP2024000504A JP 2024000504 A JP2024000504 A JP 2024000504A JP 2023083544 A JP2023083544 A JP 2023083544A JP 2023083544 A JP2023083544 A JP 2023083544A JP 2024000504 A JP2024000504 A JP 2024000504A
- Authority
- JP
- Japan
- Prior art keywords
- hsa
- mir
- hmgb1
- expression
- stem cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000014509 gene expression Effects 0.000 title claims abstract description 129
- 206010040047 Sepsis Diseases 0.000 title claims abstract description 50
- 206010069351 acute lung injury Diseases 0.000 title claims abstract description 45
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 title claims abstract description 37
- 101150021904 HMGB1 gene Proteins 0.000 title claims abstract description 35
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 title claims abstract description 35
- 201000000028 adult respiratory distress syndrome Diseases 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 title claims abstract description 34
- 230000000069 prophylactic effect Effects 0.000 title claims abstract description 12
- 229940043274 prophylactic drug Drugs 0.000 title abstract description 3
- 229940126585 therapeutic drug Drugs 0.000 title abstract description 3
- 201000010099 disease Diseases 0.000 title description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title description 8
- 239000011859 microparticle Substances 0.000 claims abstract description 127
- 239000002679 microRNA Substances 0.000 claims abstract description 59
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 46
- 108700010013 HMGB1 Proteins 0.000 claims abstract description 23
- 102000055207 HMGB1 Human genes 0.000 claims abstract description 22
- 108091070501 miRNA Proteins 0.000 claims abstract description 10
- 230000008685 targeting Effects 0.000 claims abstract description 10
- 101100339431 Arabidopsis thaliana HMGB2 gene Proteins 0.000 claims abstract 21
- 210000000130 stem cell Anatomy 0.000 claims description 147
- 210000003074 dental pulp Anatomy 0.000 claims description 104
- 239000012228 culture supernatant Substances 0.000 claims description 85
- 239000003795 chemical substances by application Substances 0.000 claims description 42
- 210000001808 exosome Anatomy 0.000 claims description 40
- 239000003814 drug Substances 0.000 claims description 21
- 108091070514 Homo sapiens let-7b stem-loop Proteins 0.000 claims description 20
- 230000001105 regulatory effect Effects 0.000 claims description 20
- 229940124597 therapeutic agent Drugs 0.000 claims description 15
- 108091068993 Homo sapiens miR-142 stem-loop Proteins 0.000 claims description 13
- 108091070380 Homo sapiens miR-92a-1 stem-loop Proteins 0.000 claims description 12
- 108091070381 Homo sapiens miR-92a-2 stem-loop Proteins 0.000 claims description 12
- 108091068853 Homo sapiens miR-100 stem-loop Proteins 0.000 claims description 11
- 108091067642 Homo sapiens miR-129-1 stem-loop Proteins 0.000 claims description 10
- 108091069093 Homo sapiens miR-129-2 stem-loop Proteins 0.000 claims description 10
- 108091067619 Homo sapiens miR-34a stem-loop Proteins 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 9
- 108091068956 Homo sapiens miR-186 stem-loop Proteins 0.000 claims description 8
- 108091070494 Homo sapiens miR-22 stem-loop Proteins 0.000 claims description 8
- -1 hsa-miR-4532 Proteins 0.000 claims description 7
- 108091070508 Homo sapiens let-7e stem-loop Proteins 0.000 claims description 4
- 108091069046 Homo sapiens let-7g stem-loop Proteins 0.000 claims description 4
- 108091068855 Homo sapiens miR-103a-1 stem-loop Proteins 0.000 claims description 4
- 108091068838 Homo sapiens miR-103a-2 stem-loop Proteins 0.000 claims description 4
- 108091065165 Homo sapiens miR-106b stem-loop Proteins 0.000 claims description 4
- 108091068928 Homo sapiens miR-107 stem-loop Proteins 0.000 claims description 4
- 108091045833 Homo sapiens miR-1179 stem-loop Proteins 0.000 claims description 4
- 108091045829 Homo sapiens miR-1183 stem-loop Proteins 0.000 claims description 4
- 108091044936 Homo sapiens miR-1236 stem-loop Proteins 0.000 claims description 4
- 108091044937 Homo sapiens miR-1237 stem-loop Proteins 0.000 claims description 4
- 108091044882 Homo sapiens miR-1247 stem-loop Proteins 0.000 claims description 4
- 108091044975 Homo sapiens miR-1304 stem-loop Proteins 0.000 claims description 4
- 108091044678 Homo sapiens miR-1307 stem-loop Proteins 0.000 claims description 4
- 108091068991 Homo sapiens miR-141 stem-loop Proteins 0.000 claims description 4
- 108091069002 Homo sapiens miR-145 stem-loop Proteins 0.000 claims description 4
- 108091067654 Homo sapiens miR-148a stem-loop Proteins 0.000 claims description 4
- 108091067009 Homo sapiens miR-148b stem-loop Proteins 0.000 claims description 4
- 108091069088 Homo sapiens miR-150 stem-loop Proteins 0.000 claims description 4
- 108091070489 Homo sapiens miR-17 stem-loop Proteins 0.000 claims description 4
- 108091092213 Homo sapiens miR-181d stem-loop Proteins 0.000 claims description 4
- 108091070490 Homo sapiens miR-18a stem-loop Proteins 0.000 claims description 4
- 108091079273 Homo sapiens miR-1913 stem-loop Proteins 0.000 claims description 4
- 108091092301 Homo sapiens miR-193b stem-loop Proteins 0.000 claims description 4
- 108091039003 Homo sapiens miR-1976 stem-loop Proteins 0.000 claims description 4
- 108091067470 Homo sapiens miR-204 stem-loop Proteins 0.000 claims description 4
- 108091067482 Homo sapiens miR-205 stem-loop Proteins 0.000 claims description 4
- 108091069013 Homo sapiens miR-206 stem-loop Proteins 0.000 claims description 4
- 108091070496 Homo sapiens miR-20a stem-loop Proteins 0.000 claims description 4
- 108091032024 Homo sapiens miR-20b stem-loop Proteins 0.000 claims description 4
- 108091067471 Homo sapiens miR-211 stem-loop Proteins 0.000 claims description 4
- 108091067466 Homo sapiens miR-212 stem-loop Proteins 0.000 claims description 4
- 108091067464 Homo sapiens miR-218-1 stem-loop Proteins 0.000 claims description 4
- 108091067463 Homo sapiens miR-218-2 stem-loop Proteins 0.000 claims description 4
- 108091070373 Homo sapiens miR-24-1 stem-loop Proteins 0.000 claims description 4
- 108091070374 Homo sapiens miR-24-2 stem-loop Proteins 0.000 claims description 4
- 108091070399 Homo sapiens miR-26b stem-loop Proteins 0.000 claims description 4
- 108091086634 Homo sapiens miR-300 stem-loop Proteins 0.000 claims description 4
- 108091067264 Homo sapiens miR-302c stem-loop Proteins 0.000 claims description 4
- 108091067007 Homo sapiens miR-324 stem-loop Proteins 0.000 claims description 4
- 108091067005 Homo sapiens miR-328 stem-loop Proteins 0.000 claims description 4
- 108091032624 Homo sapiens miR-329-1 stem-loop Proteins 0.000 claims description 4
- 108091032639 Homo sapiens miR-329-2 stem-loop Proteins 0.000 claims description 4
- 108091066899 Homo sapiens miR-340 stem-loop Proteins 0.000 claims description 4
- 108091067259 Homo sapiens miR-362 stem-loop Proteins 0.000 claims description 4
- 108091067564 Homo sapiens miR-373 stem-loop Proteins 0.000 claims description 4
- 108091067554 Homo sapiens miR-381 stem-loop Proteins 0.000 claims description 4
- 108091053847 Homo sapiens miR-410 stem-loop Proteins 0.000 claims description 4
- 108091035049 Homo sapiens miR-4275 stem-loop Proteins 0.000 claims description 4
- 108091034227 Homo sapiens miR-4284 stem-loop Proteins 0.000 claims description 4
- 108091035072 Homo sapiens miR-4324 stem-loop Proteins 0.000 claims description 4
- 108091055447 Homo sapiens miR-4460 stem-loop Proteins 0.000 claims description 4
- 108091023268 Homo sapiens miR-4638 stem-loop Proteins 0.000 claims description 4
- 108091023137 Homo sapiens miR-4673 stem-loop Proteins 0.000 claims description 4
- 108091023073 Homo sapiens miR-4691 stem-loop Proteins 0.000 claims description 4
- 108091023095 Homo sapiens miR-4707 stem-loop Proteins 0.000 claims description 4
- 108091093122 Homo sapiens miR-4727 stem-loop Proteins 0.000 claims description 4
- 108091064279 Homo sapiens miR-4793 stem-loop Proteins 0.000 claims description 4
- 108091092297 Homo sapiens miR-495 stem-loop Proteins 0.000 claims description 4
- 108091064365 Homo sapiens miR-505 stem-loop Proteins 0.000 claims description 4
- 108091092274 Homo sapiens miR-512-1 stem-loop Proteins 0.000 claims description 4
- 108091092275 Homo sapiens miR-512-2 stem-loop Proteins 0.000 claims description 4
- 108091030820 Homo sapiens miR-5193 stem-loop Proteins 0.000 claims description 4
- 108091030830 Homo sapiens miR-5196 stem-loop Proteins 0.000 claims description 4
- 108091092281 Homo sapiens miR-520a stem-loop Proteins 0.000 claims description 4
- 108091064446 Homo sapiens miR-520d stem-loop Proteins 0.000 claims description 4
- 108091064423 Homo sapiens miR-520h stem-loop Proteins 0.000 claims description 4
- 108091063810 Homo sapiens miR-539 stem-loop Proteins 0.000 claims description 4
- 108091063723 Homo sapiens miR-582 stem-loop Proteins 0.000 claims description 4
- 108091061616 Homo sapiens miR-652 stem-loop Proteins 0.000 claims description 4
- 108091061672 Homo sapiens miR-660 stem-loop Proteins 0.000 claims description 4
- 108091086478 Homo sapiens miR-665 stem-loop Proteins 0.000 claims description 4
- 108091070377 Homo sapiens miR-93 stem-loop Proteins 0.000 claims description 4
- 108091007774 MIR107 Proteins 0.000 claims description 4
- 206010038687 Respiratory distress Diseases 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 102100037907 High mobility group protein B1 Human genes 0.000 description 118
- 101001025337 Homo sapiens High mobility group protein B1 Proteins 0.000 description 117
- 108700011259 MicroRNAs Proteins 0.000 description 76
- 239000000203 mixture Substances 0.000 description 43
- 210000004027 cell Anatomy 0.000 description 37
- 210000002966 serum Anatomy 0.000 description 15
- 238000011282 treatment Methods 0.000 description 14
- 239000003112 inhibitor Substances 0.000 description 11
- 238000012258 culturing Methods 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 210000001988 somatic stem cell Anatomy 0.000 description 9
- 208000000575 Arteriosclerosis Obliterans Diseases 0.000 description 8
- 208000030831 Peripheral arterial occlusive disease Diseases 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 102000040430 polynucleotide Human genes 0.000 description 8
- 108091033319 polynucleotide Proteins 0.000 description 8
- 239000002157 polynucleotide Substances 0.000 description 8
- 210000003954 umbilical cord Anatomy 0.000 description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 7
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 7
- 210000004489 deciduous teeth Anatomy 0.000 description 7
- 210000005258 dental pulp stem cell Anatomy 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 108091053494 miR-22 stem-loop Proteins 0.000 description 7
- 108091034121 miR-92a stem-loop Proteins 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 241000282412 Homo Species 0.000 description 6
- 206010021143 Hypoxia Diseases 0.000 description 6
- 206010047115 Vasculitis Diseases 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 102000004127 Cytokines Human genes 0.000 description 5
- 108090000695 Cytokines Proteins 0.000 description 5
- 239000012091 fetal bovine serum Substances 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 230000002757 inflammatory effect Effects 0.000 description 5
- 230000028709 inflammatory response Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 102100021943 C-C motif chemokine 2 Human genes 0.000 description 4
- 101710155857 C-C motif chemokine 2 Proteins 0.000 description 4
- 101000863883 Homo sapiens Sialic acid-binding Ig-like lectin 9 Proteins 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 238000011529 RT qPCR Methods 0.000 description 4
- 102100029965 Sialic acid-binding Ig-like lectin 9 Human genes 0.000 description 4
- 230000033115 angiogenesis Effects 0.000 description 4
- 230000006907 apoptotic process Effects 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000002158 endotoxin Substances 0.000 description 4
- 239000010419 fine particle Substances 0.000 description 4
- 229920006008 lipopolysaccharide Polymers 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 108091028159 miR-92a-1 stem-loop Proteins 0.000 description 4
- 108091025616 miR-92a-2 stem-loop Proteins 0.000 description 4
- 108091049973 miR-92a-4 stem-loop Proteins 0.000 description 4
- 238000010172 mouse model Methods 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 239000012679 serum free medium Substances 0.000 description 4
- 230000019491 signal transduction Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- HIJMSZGHKQPPJS-UHFFFAOYSA-N 3-(6-methylpyridin-2-yl)-n-phenyl-4-quinolin-4-ylpyrazole-1-carbothioamide Chemical compound CC1=CC=CC(C=2C(=CN(N=2)C(=S)NC=2C=CC=CC=2)C=2C3=CC=CC=C3N=CC=2)=N1 HIJMSZGHKQPPJS-UHFFFAOYSA-N 0.000 description 3
- 102100027221 CD81 antigen Human genes 0.000 description 3
- 102100037904 CD9 antigen Human genes 0.000 description 3
- 102000001267 GSK3 Human genes 0.000 description 3
- 102100027619 Histidine-rich glycoprotein Human genes 0.000 description 3
- 101000914479 Homo sapiens CD81 antigen Proteins 0.000 description 3
- 101000738354 Homo sapiens CD9 antigen Proteins 0.000 description 3
- 101000616738 Homo sapiens NAD-dependent protein deacetylase sirtuin-6 Proteins 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 102100021840 NAD-dependent protein deacetylase sirtuin-6 Human genes 0.000 description 3
- 108010057466 NF-kappa B Proteins 0.000 description 3
- 102000003945 NF-kappa B Human genes 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000004900 autophagic degradation Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 210000002889 endothelial cell Anatomy 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 108010044853 histidine-rich proteins Proteins 0.000 description 3
- 230000007954 hypoxia Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 108091092072 miR-100 stem-loop Proteins 0.000 description 3
- 108091024975 miR-100-1 stem-loop Proteins 0.000 description 3
- 108091041879 miR-100-2 stem-loop Proteins 0.000 description 3
- 108091079658 miR-142-1 stem-loop Proteins 0.000 description 3
- 108091071830 miR-142-2 stem-loop Proteins 0.000 description 3
- 108091029119 miR-34a stem-loop Proteins 0.000 description 3
- 108091041519 miR-92a-3 stem-loop Proteins 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 238000007481 next generation sequencing Methods 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 210000004940 nucleus Anatomy 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000003449 preventive effect Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001172 regenerating effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000011476 stem cell transplantation Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 108091032955 Bacterial small RNA Proteins 0.000 description 2
- 102100025222 CD63 antigen Human genes 0.000 description 2
- 208000019736 Cranial nerve disease Diseases 0.000 description 2
- 102100039818 Frizzled-5 Human genes 0.000 description 2
- 108010014905 Glycogen Synthase Kinase 3 Proteins 0.000 description 2
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 2
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 2
- 101000934368 Homo sapiens CD63 antigen Proteins 0.000 description 2
- 101000885585 Homo sapiens Frizzled-5 Proteins 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 239000007760 Iscove's Modified Dulbecco's Medium Substances 0.000 description 2
- 208000019693 Lung disease Diseases 0.000 description 2
- 102000043136 MAP kinase family Human genes 0.000 description 2
- 108091054455 MAP kinase family Proteins 0.000 description 2
- 108091030146 MiRBase Proteins 0.000 description 2
- 108091028066 Mir-126 Proteins 0.000 description 2
- 206010028851 Necrosis Diseases 0.000 description 2
- 102000008052 Nitric Oxide Synthase Type III Human genes 0.000 description 2
- 108010075520 Nitric Oxide Synthase Type III Proteins 0.000 description 2
- 108091000080 Phosphotransferase Proteins 0.000 description 2
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
- 102000013275 Somatomedins Human genes 0.000 description 2
- 108010009583 Transforming Growth Factors Proteins 0.000 description 2
- 102000009618 Transforming Growth Factors Human genes 0.000 description 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 206010000891 acute myocardial infarction Diseases 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000004413 cardiac myocyte Anatomy 0.000 description 2
- 239000012930 cell culture fluid Substances 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000001612 chondrocyte Anatomy 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 210000004443 dendritic cell Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 239000002612 dispersion medium Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000003511 endothelial effect Effects 0.000 description 2
- 210000003979 eosinophil Anatomy 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000001146 hypoxic effect Effects 0.000 description 2
- 208000026278 immune system disease Diseases 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000001361 intraarterial administration Methods 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- YWXYYJSYQOXTPL-SLPGGIOYSA-N isosorbide mononitrate Chemical compound [O-][N+](=O)O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 YWXYYJSYQOXTPL-SLPGGIOYSA-N 0.000 description 2
- 108091091807 let-7a stem-loop Proteins 0.000 description 2
- 108091057746 let-7a-4 stem-loop Proteins 0.000 description 2
- 108091028376 let-7a-5 stem-loop Proteins 0.000 description 2
- 108091024393 let-7a-6 stem-loop Proteins 0.000 description 2
- 108091091174 let-7a-7 stem-loop Proteins 0.000 description 2
- 108091007423 let-7b Proteins 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 108091040501 miR-129 stem-loop Proteins 0.000 description 2
- 108091038720 miR-129-1 stem-loop Proteins 0.000 description 2
- 108091064138 miR-129-2 stem-loop Proteins 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- RDSACQWTXKSHJT-NSHDSACASA-N n-[3,4-difluoro-2-(2-fluoro-4-iodoanilino)-6-methoxyphenyl]-1-[(2s)-2,3-dihydroxypropyl]cyclopropane-1-sulfonamide Chemical compound C1CC1(C[C@H](O)CO)S(=O)(=O)NC=1C(OC)=CC(F)=C(F)C=1NC1=CC=C(I)C=C1F RDSACQWTXKSHJT-NSHDSACASA-N 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 201000008482 osteoarthritis Diseases 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 108010071584 oxidized low density lipoprotein Proteins 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 102000020233 phosphotransferase Human genes 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000012879 subculture medium Substances 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- LBPKYPYHDKKRFS-UHFFFAOYSA-N 1,5-naphthyridine, 2-[3-(6-methyl-2-pyridinyl)-1h-pyrazol-4-yl]- Chemical compound CC1=CC=CC(C2=C(C=NN2)C=2N=C3C=CC=NC3=CC=2)=N1 LBPKYPYHDKKRFS-UHFFFAOYSA-N 0.000 description 1
- CDKIEBFIMCSCBB-UHFFFAOYSA-N 1-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-3-(1-methyl-2-phenylpyrrolo[2,3-b]pyridin-3-yl)prop-2-en-1-one;hydrochloride Chemical compound Cl.C1C=2C=C(OC)C(OC)=CC=2CCN1C(=O)C=CC(C1=CC=CN=C1N1C)=C1C1=CC=CC=C1 CDKIEBFIMCSCBB-UHFFFAOYSA-N 0.000 description 1
- GFMMXOIFOQCCGU-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide Chemical compound C=1C=C(I)C=C(Cl)C=1NC1=C(F)C(F)=CC=C1C(=O)NOCC1CC1 GFMMXOIFOQCCGU-UHFFFAOYSA-N 0.000 description 1
- CMJVDHCUKXXBFF-UHFFFAOYSA-N 2-[2-(5-chloro-2-fluorophenyl)pteridin-4-yl]pyridin-4-amine Chemical compound NC1=CC=NC(C=2C3=NC=CN=C3N=C(N=2)C=2C(=CC=C(Cl)C=2)F)=C1 CMJVDHCUKXXBFF-UHFFFAOYSA-N 0.000 description 1
- JHTMDHCOOUQCHN-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-4-yl)-2-tert-butyl-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(NC(=N2)C(C)(C)C)C=2C=3OCOC=3C=CC=2)=N1 JHTMDHCOOUQCHN-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 101100165655 Arabidopsis thaliana BRO1 gene Proteins 0.000 description 1
- 101100178203 Arabidopsis thaliana HMGB3 gene Proteins 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 102000015735 Beta-catenin Human genes 0.000 description 1
- 108060000903 Beta-catenin Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 102100035888 Caveolin-1 Human genes 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102100037241 Endoglin Human genes 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 102100028071 Fibroblast growth factor 7 Human genes 0.000 description 1
- 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 1
- 108010009307 Forkhead Box Protein O3 Proteins 0.000 description 1
- 102100035421 Forkhead box protein O3 Human genes 0.000 description 1
- 108060006662 GSK3 Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 101150091750 HMG1 gene Proteins 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 101800001649 Heparin-binding EGF-like growth factor Proteins 0.000 description 1
- 101000715467 Homo sapiens Caveolin-1 Proteins 0.000 description 1
- 101000881679 Homo sapiens Endoglin Proteins 0.000 description 1
- 101000847538 Homo sapiens Flotillin-1 Proteins 0.000 description 1
- 101100082597 Homo sapiens PDCD6IP gene Proteins 0.000 description 1
- 101000779418 Homo sapiens RAC-alpha serine/threonine-protein kinase Proteins 0.000 description 1
- 101000798015 Homo sapiens RAC-beta serine/threonine-protein kinase Proteins 0.000 description 1
- 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 1
- 101000613251 Homo sapiens Tumor susceptibility gene 101 protein Proteins 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- 241000186779 Listeria monocytogenes Species 0.000 description 1
- 108091028080 MiR-132 Proteins 0.000 description 1
- 108091026807 MiR-214 Proteins 0.000 description 1
- 102100025744 Mothers against decapentaplegic homolog 1 Human genes 0.000 description 1
- 102100025751 Mothers against decapentaplegic homolog 2 Human genes 0.000 description 1
- 101710143123 Mothers against decapentaplegic homolog 2 Proteins 0.000 description 1
- 102100025748 Mothers against decapentaplegic homolog 3 Human genes 0.000 description 1
- 101710143111 Mothers against decapentaplegic homolog 3 Proteins 0.000 description 1
- 102100030610 Mothers against decapentaplegic homolog 5 Human genes 0.000 description 1
- 101710143113 Mothers against decapentaplegic homolog 5 Proteins 0.000 description 1
- 208000004221 Multiple Trauma Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108091008099 NLRP3 inflammasome Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102100025386 Oxidized low-density lipoprotein receptor 1 Human genes 0.000 description 1
- 101710199789 Oxidized low-density lipoprotein receptor 1 Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 102100033344 Programmed cell death 6-interacting protein Human genes 0.000 description 1
- 102100033762 Proheparin-binding EGF-like growth factor Human genes 0.000 description 1
- 102100033810 RAC-alpha serine/threonine-protein kinase Human genes 0.000 description 1
- 102100032315 RAC-beta serine/threonine-protein kinase Human genes 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 102100029753 Reduced folate transporter Human genes 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
- 101700032040 SMAD1 Proteins 0.000 description 1
- 241000277331 Salmonidae Species 0.000 description 1
- 241000269851 Sarda sarda Species 0.000 description 1
- 108010047827 Sialic Acid Binding Immunoglobulin-like Lectins Proteins 0.000 description 1
- 102000007073 Sialic Acid Binding Immunoglobulin-like Lectins Human genes 0.000 description 1
- 102000000344 Sirtuin 1 Human genes 0.000 description 1
- 108010041191 Sirtuin 1 Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 108091005735 TGF-beta receptors Proteins 0.000 description 1
- 108700031126 Tetraspanins Proteins 0.000 description 1
- 102000043977 Tetraspanins Human genes 0.000 description 1
- 102000002689 Toll-like receptor Human genes 0.000 description 1
- 108020000411 Toll-like receptor Proteins 0.000 description 1
- 102100039360 Toll-like receptor 4 Human genes 0.000 description 1
- 102000006747 Transforming Growth Factor alpha Human genes 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 102000016715 Transforming Growth Factor beta Receptors Human genes 0.000 description 1
- 102000004060 Transforming Growth Factor-beta Type II Receptor Human genes 0.000 description 1
- 108010082684 Transforming Growth Factor-beta Type II Receptor Proteins 0.000 description 1
- 101800004564 Transforming growth factor alpha Proteins 0.000 description 1
- 102100040879 Tumor susceptibility gene 101 protein Human genes 0.000 description 1
- CFQULUVMLGZVAF-OYJDLGDISA-N U0126.EtOH Chemical compound CCO.C=1C=CC=C(N)C=1SC(\N)=C(/C#N)\C(\C#N)=C(/N)SC1=CC=CC=C1N CFQULUVMLGZVAF-OYJDLGDISA-N 0.000 description 1
- 208000024248 Vascular System injury Diseases 0.000 description 1
- 208000012339 Vascular injury Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- HUDSYNWJCPDHLL-CJLVFECKSA-N [(E)-[2-(6-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino] acetate Chemical compound CC(=O)O\N=C1\C(=Nc2ccccc12)c1c(O)[nH]c2cc(Br)ccc12 HUDSYNWJCPDHLL-CJLVFECKSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 230000008568 cell cell communication Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 210000002583 cell-derived microparticle Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 238000011976 chest X-ray Methods 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012468 concentrated sample Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 210000001968 dental pulp cell Anatomy 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 208000009190 disseminated intravascular coagulation Diseases 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 238000002296 dynamic light scattering Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000004528 endothelial cell apoptotic process Effects 0.000 description 1
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 1
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 229960002435 fasudil Drugs 0.000 description 1
- NGOGFTYYXHNFQH-UHFFFAOYSA-N fasudil Chemical compound C=1C=CC2=CN=CC=C2C=1S(=O)(=O)N1CCCNCC1 NGOGFTYYXHNFQH-UHFFFAOYSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000012595 freezing medium Substances 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 108091005996 glycated proteins Proteins 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 210000003897 hepatic stem cell Anatomy 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 208000018875 hypoxemia Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 108091005434 innate immune receptors Proteins 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 108091050724 let-7b stem-loop Proteins 0.000 description 1
- 108091063986 let-7f stem-loop Proteins 0.000 description 1
- 201000002818 limb ischemia Diseases 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 108091040751 miR-130a stem-loop Proteins 0.000 description 1
- 108091041344 miR-130a-1 stem-loop Proteins 0.000 description 1
- 108091091365 miR-130a-2 stem-loop Proteins 0.000 description 1
- 108091043162 miR-133b stem-loop Proteins 0.000 description 1
- 108091088765 miR-133b-1 stem-loop Proteins 0.000 description 1
- 108091074641 miR-133b-2 stem-loop Proteins 0.000 description 1
- 108091062762 miR-21 stem-loop Proteins 0.000 description 1
- 108091041631 miR-21-1 stem-loop Proteins 0.000 description 1
- 108091044442 miR-21-2 stem-loop Proteins 0.000 description 1
- 108091048308 miR-210 stem-loop Proteins 0.000 description 1
- 108091035591 miR-23a stem-loop Proteins 0.000 description 1
- 108091045911 miR-23a-1 stem-loop Proteins 0.000 description 1
- 108091047979 miR-23a-2 stem-loop Proteins 0.000 description 1
- 108091032054 miR-23a-3 stem-loop Proteins 0.000 description 1
- 108091029166 miR-23a-4 stem-loop Proteins 0.000 description 1
- 108091063344 miR-30b stem-loop Proteins 0.000 description 1
- 108091055059 miR-30c stem-loop Proteins 0.000 description 1
- 108091027983 miR-378-1 stem-loop Proteins 0.000 description 1
- 108091089716 miR-378-2 stem-loop Proteins 0.000 description 1
- 108091030938 miR-424 stem-loop Proteins 0.000 description 1
- 230000005486 microgravity Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002829 mitogen activated protein kinase inhibitor Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000002487 multivesicular body Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- NFVJNJQRWPQVOA-UHFFFAOYSA-N n-[2-chloro-5-(trifluoromethyl)phenyl]-2-[3-(4-ethyl-5-ethylsulfanyl-1,2,4-triazol-3-yl)piperidin-1-yl]acetamide Chemical compound CCN1C(SCC)=NN=C1C1CN(CC(=O)NC=2C(=CC=C(C=2)C(F)(F)F)Cl)CCC1 NFVJNJQRWPQVOA-UHFFFAOYSA-N 0.000 description 1
- YOVNFNXUCOWYSG-UHFFFAOYSA-N n-[3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-6-yl]oxyphenyl]-4-(2-morpholin-4-ylethoxy)benzamide Chemical compound C1=C2N(CC)C(C=3C(=NON=3)N)=NC2=CN=C1OC(C=1)=CC=CC=1NC(=O)C(C=C1)=CC=C1OCCN1CCOCC1 YOVNFNXUCOWYSG-UHFFFAOYSA-N 0.000 description 1
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 229940097496 nasal spray Drugs 0.000 description 1
- 210000001178 neural stem cell Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000207 pro-atherogenic effect Effects 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000006010 pyroptosis Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000010410 reperfusion Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 230000000250 revascularization Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- CYOHGALHFOKKQC-UHFFFAOYSA-N selumetinib Chemical compound OCCONC(=O)C=1C=C2N(C)C=NC2=C(F)C=1NC1=CC=C(Br)C=C1Cl CYOHGALHFOKKQC-UHFFFAOYSA-N 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000005740 tumor formation Effects 0.000 description 1
- 229940046728 tumor necrosis factor alpha inhibitor Drugs 0.000 description 1
- 239000002451 tumor necrosis factor inhibitor Substances 0.000 description 1
- 210000003606 umbilical vein Anatomy 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2023/021640 WO2023248844A1 (ja) | 2022-06-20 | 2023-06-12 | Ｈｍｇｂ１の発現制御剤；急性肺損傷、急性呼吸窮迫症候群または敗血症の予防薬または治療薬、あるいはそれらの改善方法 |
| EP23827030.0A EP4541358A1 (en) | 2022-06-20 | 2023-06-12 | Hmgb1 expression suppressor, prophylactic or therapeutic drug for acute lung injury, acute respiratory distress syndrome or sepsis, and method for ameliorating such disease |
| US18/877,773 US20250382614A1 (en) | 2022-06-20 | 2023-06-12 | Hmgb1 expression regulator, prophylactic agent or therapeutic agent for acute lung injury, acute respiratory distress syndrome, or sepsis, or method of ameliorating same |
| CN202380046684.6A CN119365204A (zh) | 2022-06-20 | 2023-06-12 | Hmgb1的表达调控剂；急性肺损伤、急性呼吸窘迫综合征或败血症的预防药或治疗药，或它们的改善方法 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022098639 | 2022-06-20 | ||
| JP2022098639 | 2022-06-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2024000504A true JP2024000504A (ja) | 2024-01-05 |
Family
ID=89384628
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023083544A Pending JP2024000504A (ja) | 2022-06-20 | 2023-05-20 | Ｈｍｇｂ１の発現制御剤；急性肺損傷、急性呼吸窮迫症候群または敗血症の予防薬または治療薬、あるいはそれらの改善方法 |
| JP2023083545A Pending JP2024000505A (ja) | 2022-06-20 | 2023-05-20 | Ｐｔｘ３の発現制御剤；関節リウマチ、自己免疫疾患に伴う血管炎または皮膚硬化の予防薬または治療薬、あるいはそれらの改善方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023083545A Pending JP2024000505A (ja) | 2022-06-20 | 2023-05-20 | Ｐｔｘ３の発現制御剤；関節リウマチ、自己免疫疾患に伴う血管炎または皮膚硬化の予防薬または治療薬、あるいはそれらの改善方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (2) | JP2024000504A (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2025170079A1 (https=) * | 2024-02-09 | 2025-08-14 | ||
| WO2025181030A1 (en) * | 2024-02-26 | 2025-09-04 | Fundació Institut D'investigació I Innovació Parc Taulí | Therapy for inflammatory lung diseases |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10709741B2 (en) * | 2013-02-13 | 2020-07-14 | National University Corporation Nagoya University | Composition for preventing or treating inflammatory disease |
-
2023
- 2023-05-20 JP JP2023083544A patent/JP2024000504A/ja active Pending
- 2023-05-20 JP JP2023083545A patent/JP2024000505A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024000505A (ja) | 2024-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6894652B1 (ja) | 組織修復剤、組織修復剤の使用方法およびスクリーニング方法 | |
| JP7492757B2 (ja) | 遺伝子の発現制御剤、アルツハイマー病の予防薬または治療薬および認知症の改善方法 | |
| JP2024000504A (ja) | Ｈｍｇｂ１の発現制御剤；急性肺損傷、急性呼吸窮迫症候群または敗血症の予防薬または治療薬、あるいはそれらの改善方法 | |
| EP4596682A1 (en) | Fine particles, nk cell activator, culture method for nk cells, production method for activated nk cells, and activation method for nk cells | |
| US20230321152A1 (en) | Cytokine storm suppressor, method for using cytokine storm suppressor and screening method | |
| WO2023190267A1 (ja) | 微小粒子、パーキンソン病の予防薬または治療薬およびパーキンソン病の改善方法 | |
| JP6974892B1 (ja) | 癌悪液質の改善剤および癌悪液質の改善方法 | |
| JP2025032034A (ja) | 若返り剤および若返り方法 | |
| JP7720630B2 (ja) | 微小粒子、勃起不全の予防薬または治療薬および勃起不全の改善方法 | |
| WO2023248844A1 (ja) | Ｈｍｇｂ１の発現制御剤；急性肺損傷、急性呼吸窮迫症候群または敗血症の予防薬または治療薬、あるいはそれらの改善方法 | |
| WO2023199828A1 (ja) | 微小粒子、血管新生眼疾患の予防薬または治療薬および血管新生眼疾患の改善方法 | |
| EP4541359A1 (en) | Ptx3 expression control agent, prophylactic drug or therapeutic drug for vasculitis or hardening of skin associated with rheumatoid arthritis, autoimmune disease, method for improving vasculitis or hardening of skin associated with rheumatoid arthritis, autoimmune disease | |
| JP2025095535A (ja) | Ｐｔｘ３の発現制御剤；関節リウマチ、自己免疫疾患に伴う血管炎または皮膚硬化の予防薬または治療薬、あるいはそれらの改善方法 | |
| WO2023199829A1 (ja) | 微小粒子、うつ病の予防薬または治療薬およびうつ病の改善方法 | |
| WO2026009923A1 (ja) | がん微小環境の改善剤、抗腫瘍免疫応答の予防薬または治療薬およびがん微小環境の改善方法 | |
| JP2025172276A (ja) | 遺伝子の発現制御剤、アルツハイマー病の予防薬または治療薬および認知症の改善方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AA64 | Notification of invalidation of claim of internal priority (with term) |
Free format text: JAPANESE INTERMEDIATE CODE: A241764 Effective date: 20230613 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230618 |